PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Tian-Men-Dong decoction suppressed tumour-infiltrating G-MDSCs in an orthotopic lung cancer mouse model [PMID:37072091].
Asparagus polysaccharide alleviated aortic lesions and decreased serum lipid levels in ApoE-/- mice [PMID:40571003].
Aqueous extract of root (ACE) decreased weight gain, relieved dyslipidemia, and improved glucose tolerance and insulin resistance in HFD-induced obese mice [PMID:36313282].
Extract ameliorated depression-like behavior in ovariectomized rats under chronic unpredictable mild stress [PMID:33109198].
Oligosaccharides from Asparagi radix reduced NO production and down-regulated IL-6, IL-1β, and TNF-α in LPS-induced models [PMID:38376424].
Evidence summary
PubMed sources
- 1.PMID: 37072091 (2023) — The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer. · Journal of ethnopharmacology
- 2.PMID: 36532772 (2022) — Asparagus cochinchinensis: A review of its botany, traditional uses, phytochemistry, pharmacology, and applications. · Frontiers in pharmacology
- 3.PMID: 35178192 (2021) — Bioactive small-molecule constituents of Lao plants. · Journal of medicinal plant research
- 4.PMID: 14987058 (2004) — Bioactive constituents from Asparagus cochinchinensis. · Journal of natural products
- 5.PMID: 15008456 (2004) — Furostanol oligoglycosides from Asparagus cochinchinensis.